Harvard Apparatus Regenerative Technology,
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch HRGN and buy or sell other stocks, ETFs, and their options commission-free!About HRGN
Harvard Apparatus Regenerative Technology, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function.
CEOJun Li He
CEOJun Li He
Employees8
Employees8
HeadquartersHolliston, Massachusetts
HeadquartersHolliston, Massachusetts
Founded2012
Founded2012
Employees8
Employees8
HRGN Key Statistics
Market cap28.65M
Market cap28.65M
Price-Earnings ratio-3.40
Price-Earnings ratio-3.40
Dividend yield—
Dividend yield—
Average volume1.70K
Average volume1.70K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.90
52 Week high$5.90
52 Week low$1.74
52 Week low$1.74